"Mount Sinai Launches Immunology Hub for Genomic, Machine Learning Research" - Andrea Park
A new Center for Computational Immunology at the Icahn School of Medicine at Mount Sinai will serve as a research hub for the study and discovery of targeted immunotherapies for cancer patients. “The center aims to increase the number of patients who benefit from cancer-killing immunotherapy drugs. To do so, researchers will utilize genomics, machine learning and immunology, and look further into the tumor microenvironment for answers," said Miriam Merad, MD, PhD, professor of medicine, hematology and medical oncology, and oncological sciences at the Icahn School of Medicine at Mount Sinai. "We want to understand how to model interactions between cancers and the immune system to help more people benefit from the life-saving potential of immunotherapy," said Benjamin Greenbaum, PhD, assistant professor of oncological sciences, pathology and medicine at the Icahn School of Medicine at Mount Sinai.
— Miriam Merad, MD, PhD, Professor, Medicine, Hematology and Medical Oncology, Oncological Sciences, Director, Precision Immunology Institute, Co-Director, Cancer Immunology Program, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
— Benjamin D. Greenbaum, PhD, Assistant Professor, Medicine, Hematology and Medical Oncology, Pathology, Oncological Sciences, Icahn School of Medicine at Mount Sinai
Additional coverage: Health Data Management
Researchers Discover Potential Boost to Immunotherapy
Mar 30, 2020 View All Press Releases